Skip to main content

Table 3 Fasting plasma insulin and incidence of AF analysed with competing risks regression considering mortality as a competing event

From: Low fasting plasma insulin is associated with atrial fibrillation in men from a cohort study - the Malmö preventive project

  

Model 1

Model 2

  

SHR

95% CI

P

SHR

95% CI

P

Both genders

Ln-Insulin

0.81

0.74-0.88

<.0001

0.80

0.73-0.88

<.0001

Quartile 1

reference

     

Quartile 2

0.99

0.83-1.18

.89

0.99

0.83-1.17

.89

Quartile 3

0.78

0.65-0.94

0.008

0.78

0.64-0.93

0.007

Quartile 4

0.69

0.57-0.84

<.0001

0.69

0.57-0.83

<.0001

Men

Ln-Insulin

0.80

0.73-0.88

<.0001

0.80

0.72-0.87

<.0001

Quartile 1

reference

     

Quartile 2

0.95

0.79-1.14

0.59

0.95

0.80-1.14

0.60

Quartile 3

0.75

0.62-0.92

0.005

0.75

0.62-0.92

0.005

Quartile 4

0.66

0.54-0.81

<.0001

0.65

0.53-0.80

<.0001

Women

Ln-Insulin

0.89

0.69-1.15

0.39

0.87

0.68-1.13

0.31

Quartile 1

reference

     

Quartile 2

1.25

0.68-2.31

0.47

1.22

0.66-2.26

0.52

Quartile 3

0.94

0.57-1.57

0.82

0.94

0.56-1.57

0.82

Quartile 4

1.02

0.61-1.70

0.93

0.98

0.59-1.64

0.95

  1. Based on 7066 individuals (6052 men and 1014 women) and 983 cases. Model 1 is adjusted for age, sex (where applicable), height and weight. Model 2 is adjusted for Model 1 covariates + systolic blood pressure and smoking status. SHR for ln-Insulin is expressed per log unit. SHR = sub-hazards ratio from a competing risk regression.
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us